Stock Scorecard
Stock Summary for Savara Inc (SVRA) - $3.56 as of 9/12/2025 9:28:33 PM EST
Total Score
5 out of 30
Safety Score
33 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SVRA
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SVRA
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SVRA
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SVRA
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for SVRA (33 out of 100)
Stock Price Rating (Max of 10) | 3 |
Historical Stock Price Rating (Max of 10) | 2 |
Stock Price Trend (Max of 10) | 10 |
Book Value (Max of 10) | 1 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 4 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 9 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SVRA
Financial Details for SVRA
Company Overview |
|
---|---|
Ticker | SVRA |
Company Name | Savara Inc |
Country | USA |
Description | Savara Inc. is a lung disease orphan company. The company is headquartered in Austin, Texas. |
Sector Name | HEALTHCARE |
Industry Name | BIOTECHNOLOGY |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 11/6/2025 |
Stock Price History |
|
Last Day Price | 3.56 |
Price 4 Years Ago | 1.24 |
Last Day Price Updated | 9/12/2025 9:28:33 PM EST |
Last Day Volume | 1,973,773 |
Average Daily Volume | 1,556,828 |
52-Week High | 4.70 |
52-Week Low | 1.89 |
Last Price to 52 Week Low | 88.36% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 21.34 |
Sector PE | 40.86 |
5-Year Average PE | -7.87 |
Free Cash Flow Ratio | 35.60 |
Industry Free Cash Flow Ratio | 13.20 |
Sector Free Cash Flow Ratio | 29.37 |
Current Ratio Most Recent Quarter | 11.08 |
Total Cash Per Share | 0.10 |
Book Value Per Share Most Recent Quarter | 0.57 |
Price to Book Ratio | 5.49 |
Industry Price to Book Ratio | 28.96 |
Sector Price to Book Ratio | 32.27 |
Price to Sales Ratio Twelve Trailing Months | 131,150.00 |
Industry Price to Sales Ratio Twelve Trailing Months | 44.01 |
Sector Price to Sales Ratio Twelve Trailing Months | 19.72 |
Analyst Buy Ratings | 4 |
Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
Total Shares Outstanding | 172,837,000 |
Market Capitalization | 615,299,720 |
Institutional Ownership | 99.91% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 4.48% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -75.29% |
Reported EPS 12 Trailing Months | -0.51 |
Reported EPS Past Year | -0.26 |
Reported EPS Prior Year | -0.47 |
Net Income Twelve Trailing Months | -110,332,000 |
Net Income Past Year | -95,881,000 |
Net Income Prior Year | -54,698,000 |
Quarterly Revenue Growth YOY | 0.00% |
5-Year Revenue Growth | -10.47% |
Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 17,436,000 |
Total Cash Past Year | 15,128,000 |
Total Cash Prior Year | 26,585,000 |
Net Cash Position Most Recent Quarter | -12,217,000 |
Net Cash Position Past Year | -11,491,000 |
Long Term Debt Past Year | 26,619,000 |
Long Term Debt Prior Year | 26,348,000 |
Total Debt Most Recent Quarter | 29,653,000 |
Equity to Debt Ratio Past Year | 0.87 |
Equity to Debt Ratio Most Recent Quarter | 0.80 |
Total Stockholder Equity Past Year | 171,449,000 |
Total Stockholder Equity Prior Year | 140,372,000 |
Total Stockholder Equity Most Recent Quarter | 120,484,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -99,429,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.58 |
Free Cash Flow Past Year | -89,113,000 |
Free Cash Flow Prior Year | -51,357,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.29 |
MACD Signal | 0.25 |
20-Day Bollinger Lower Band | 1.76 |
20-Day Bollinger Middle Band | 2.74 |
20-Day Bollinger Upper Band | 3.73 |
Beta | 0.56 |
RSI | 76.06 |
50-Day SMA | 2.96 |
150-Day SMA | 3.28 |
200-Day SMA | 2.79 |
System |
|
Modified | 9/11/2025 10:52:16 AM EST |